- FTC Adds Latvian Financial Institution, CEO to Case against Apex Capital Group ( )
- FTC Seeks Additional Public Comment on Proposed Changes to the Contact Lens Rule ( )
- FTC Returns Almost $515,000 to Consumers Who Bought Deceptively Marketed “Amniotic Stem Cell Therapy” Between 2014 and 2017 ( )
- FTC Joins FDA in Sending Warning Letters to Companies Advertising and Selling Products Containing Cannabidiol (CBD) Claiming to Treat Alzheimer’s, Cancer, and Other Diseases ( )
- FTC Returns $1.95 Million to Consumers Who Bought NutriMost Ultimate Fat Loss System in the Pittsburgh Area ( )
- FTC Approves Final Consent Order against Company and Owner Who Allegedly Made Unsupported Health Claims for Intravenously Injected Therapy Products ( )
- FTC and FDA Send Warning Letters to Companies Selling Dietary Supplements Claiming to Treat Alzheimer’s Disease and Remediate or Cure Other Serious Illnesses Such as Parkinson’s, Heart Disease, and Cancer ( )
- FTC Returns Almost $3.5 Million to Consumers Who Bought Deceptively Marketed “Weight-Loss” Supplements from Direct Alternatives and Original Organics, LLC ( )
- Online Seller to Pay $60,000 Penalty for Violating the Contact Lens Rule ( )
- “Nobetes” Dietary Supplement Marketers Settle FTC Complaint Alleging Unsubstantiated Health Claims, Illegal Billing Practices, and Deceptive Endorsements ( )
- FTC Returns more than $750,000 to Consumers Who Bought Two Deceptively Marketed Supplements from Health Research Laboratories, LLC ( )
- PR Firm and Publisher Settle FTC Allegations They Misrepresented Product Endorsements as Independent Opinions, Commercial Advertising as Editorial Content ( )
- FTC Halts Purveyors of Sham Health Insurance Plans ( )
- At FTC’s Request, Court Stops False Advertising and Unauthorized Billing Scheme ( )
- FTC Approves Final Consent Order in Aromaflage Insect Repellent Advertising Case ( )
- Court Rules in FTC’s Favor in Case against Weight-loss Supplement Marketer Roca Labs ( )
- FTC Brings First-ever Action Targeting “iV Cocktail” Therapy Marketer ( )
- FTC Halts Online Marketers Responsible for Deceptive “Free Trial” Offers ( )
- FTC Announces Refund Claim Process for Consumers Who Bought the NutriMost Weight-Loss System in the Pittsburgh Area ( )
- FTC Halts Deceptive Mosquito-Repellent Claims for Aromaflage Perfume and Candles ( )
- FTC Settlement Turns Down the Volume on Deceptive Sound Amplifier Ads ( )
- FTC Approves Final Consent Order in Telomerase Activation Sciences Deceptive Advertising Case ( )
- FTC Sending Refund Checks Totaling More Than $355,000 to Consumers Who Bought CogniPrin ‘Memory Improvement’ Supplement ( )
- FTC Sending Refund Checks Totaling More Than $437,000 to Consumers Who Bought Bogus Weight-loss Products ( )
- Advertising Firm Barred from Assisting in the Marketing and Sale of Weight-Loss Supplements Deceptively Pitched to Consumers ( )
- Marketer That Deceptively Advertised Bed Bug Treatment Admits Violating FTC Order; Will Be Barred from Bed Bug Product Sales and Pay $224,356 for Consumer Refunds ( )
- La FTC y la FDA advierten a compañías sobre la comercialización y venta de productos para la cesación de opiáceos ( )
- FTC, FDA Warn Companies about Marketing and Selling Opioid Cessation Products ( )
- Marketers Barred from Making Deceptive Claims about Products’ Ability to Mitigate Side Effects of Cancer Treatment ( )
- FTC Sending Refund Checks Totaling More Than $8 Million to Consumers Who Bought Deceptively Marketed Weight-loss Supplements ( )
El .gov significa que es oficial.
Los sitios web del gobierno federal siempre usan un dominio .gov o .mil. Antes de compartir información confidencial en línea, asegúrese de estar en un sitio .gov o .mil.
Este sitio es seguro.
El https:// medios todos los datos transmitidos son cifrados - en otras palabras, cualquier información o el historial de navegación que proporcione se transmite de forma segura.